|
EXO1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.06026298851702E-13 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.85709999600547E-08 |
| Normal-vs-Stage2 |
3.000300E-04 |
| Normal-vs-Stage3 |
1.2274999905415E-09 |
| Normal-vs-Stage4 |
1.09959999994302E-07 |
| Stage1-vs-Stage2 |
6.143800E-01 |
| Stage1-vs-Stage3 |
3.001800E-02 |
| Stage1-vs-Stage4 |
1.421860E-03 |
| Stage2-vs-Stage3 |
3.570200E-01 |
| Stage2-vs-Stage4 |
1.423920E-02 |
| Stage3-vs-Stage4 |
4.543700E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.67921232474555E-12 |
| Normal-vs-AfricanAmerican |
2.997700E-03 |
| Normal-vs-Asian |
1.861440E-01 |
| Caucasian-vs-AfricanAmerican |
1.602170E-01 |
| Caucasian-vs-Asian |
6.558800E-01 |
| AfricanAmerican-vs-Asian |
4.700200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.54674059618765E-12 |
| Normal-vs-Female |
3.08870040655052E-10 |
| Male-vs-Female |
4.182800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.037900E-03 |
| Normal-vs-Age(41-60Yrs) |
1.85919946105173E-10 |
| Normal-vs-Age(61-80Yrs) |
1.65230051862864E-11 |
| Normal-vs-Age(81-100Yrs) |
7.225900E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.954630E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.970180E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.808100E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.702400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.544380E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.325580E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
2.457200E-03 |
| Normal-vs-Grade 2 |
7.15939973972013E-10 |
| Normal-vs-Grade 3 |
1.9630963521422E-11 |
| Normal-vs-Grade 4 |
2.73109999948673E-07 |
| Grade 1-vs-Grade 2 |
2.942200E-02 |
| Grade 1-vs-Grade 3 |
5.963900E-04 |
| Grade 1-vs-Grade 4 |
6.28979999999224E-05 |
| Grade 2-vs-Grade 3 |
2.821800E-02 |
| Grade 2-vs-Grade 4 |
6.012900E-04 |
| Grade 3-vs-Grade 4 |
5.256100E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
3.8859999995644E-08 |
| Normal-vs-ccB subtype |
7.53530571273586E-12 |
| ccA subtype-vs-ccB subtype |
7.85670000000849E-05 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.06370501085485E-11 |
| Normal-vs-N1 |
7.389500E-04 |
| N0-vs-N1 |
1.208040E-02 |
|
|
